Price (delayed)
$6.1
Market cap
$435.57M
P/E Ratio
5.08
Dividend/share
$1.05
EPS
$1.2
Enterprise value
$336.3M
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company focused on the health security market. Health security comprises countermeasures for biological, chemical, radiological and nuclear attacks (biodefense market), vaccines and therapies
Special dividends are included in TTM DPS and yield
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from and Sharadar.